NEW YORK (GenomeWeb) – In order to provide access to high-value proprietary datasets owned by companies, academic institutions, and other entities, YouGene has come up with infrastructure and a business model that provides a forum for these data holders to share their information more broadly and profit from its use.

Specifically, the company has developed YouGene Connect, a platform to which entities can submit their most valuable proprietary datasets and then charge royalties or subscription fees for third parties to access and use the information.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.